Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelief Robbins-Juarez

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Case Reports in Critical Care|October 11, 2021
Ethylene Glycol Intoxication Requiring ECMO SupportRaphael Rosen, Shelief Robbins-Juarez, Jacob Stevens
Kidney360|April 4, 2022
Number of Donor Renal Arteries and Early Outcomes after Deceased Donor Kidney TransplantationS Ali Husain, Kristen L King, Shelief Robbins-Juarez, et al.
Clinical Transplantation|November 18, 2022
Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipientsPascale Khairallah, Shelief Robbins-Juarez, Shefali Patel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Case Reports in Critical Care|October 11, 2021
Ethylene Glycol Intoxication Requiring ECMO SupportRaphael Rosen, Shelief Robbins-Juarez, Jacob Stevens
Kidney360|April 4, 2022
Number of Donor Renal Arteries and Early Outcomes after Deceased Donor Kidney TransplantationS Ali Husain, Kristen L King, Shelief Robbins-Juarez, et al.
Clinical Transplantation|November 18, 2022
Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipientsPascale Khairallah, Shelief Robbins-Juarez, Shefali Patel, et al.
Pageof 1